Man Group
MRNA icon

Man Group’s Moderna MRNA Stock Holding History

Man Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-77,500
Closed -$2M – 2393
2025
Q3 		$2M Sell
77,500
-373,600
-83% -$10.4M ﹤0.01% 1421
2025
Q2 		$12.4M Buy
451,100
+93,800
+26% +$2.47M 0.02% 690
2025
Q1 		$10.1M Buy
+357,300
New +$12.7M 0.03% 724
2022
Q2 		– Sell
-100
Closed -$17K – 2286
2022
Q1 		$17K Buy
+100
New +$16.8K ﹤0.01% 2156

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's MRNA Position: Q1 2026 in Review

Man Group reduced its Moderna (MRNA) stake by 97% in Q1 2026, selling an estimated $23.5M and leaving 14,277 shares worth $725K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Man Group first reported a position in MRNA in Q4 2018 and has held it in 24 quarters since. The position peaked at $30.8M in Q3 2025. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Man Group held 14,277 shares of Moderna worth $725K as of Q1 2026.
  • Man Group sold 504,022 Moderna shares in Q1 2026, an estimated $23.5M.
  • Moderna made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1940 holding.
  • Man Group first reported a position in Moderna in Q4 2018 and has held it in 24 quarters since.
  • Man Group's Moderna position peaked at $30.8M in Q3 2025.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.